Ashesh Shah, MD
Surgery · Philadelphia, PANPI 1588822977
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,639 of the $3,710 with a category attached, or 98.1%. 4 manufacturers reported payments, led by Transmedics, Inc. at 47.6% of the total. 2025 is the largest year on record at $2,698, more than ten times the $16 reported in 2019.
Across 12 payments — averaging $309.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Transmedics, Inc.$2K
- Intuitive Surgical$996
- Organox Ltd$931
- Edwards Lifesciences$16
Across 29 payments — averaging $11,167 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$226K
- Transmedics, Inc.$98K
What the payments were for
- Travel & lodging$3,63998%
- Food & beverage$712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Transmedics, Inc. | 2 | $1,767 |
| Intuitive Surgical | 4 | $996 |
| Organox Ltd | 5 | $931 |
| Edwards Lifesciences | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORGAN CARE SYSTEM$1,767
- Da Vinci Surgical System$987
- METRA$878
How this compares
$3,710 in reported general payments places this provider in the 70th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LokelmaSodium Zirconium Cyclosilicate | 12 | $9,566 |
| Atovaquone | 19 | $7,474 |
| Valganciclovir Hcl | 28 | $5,832 |
| Ursodiol | 30 | $3,338 |
| Sodium Chloride0.9 % Sodium Chloride | 37 | $817 |
| ValacyclovirValacyclovir Hcl | 15 | $760 |
| Pantoprazole Sodium | 60 | $593 |
| Nifedipine ErNifedipine | 42 | $591 |
| Dapsone | 12 | $585 |
| Magnesium Sulfate | 37 | $407 |
| Tamsulosin Hcl | 35 | $301 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 42 | $138 |
| Gabapentin | 17 | $121 |
| Omeprazole | 11 | $101 |
| Furosemide | 11 | $70 |
Paid to pharmacies, not to this prescriber.
Other surgery in Philadelphia
- Brett ChatmanPhiladelphia$178K
- David WernsingPhiladelphia$142K
- Said AzouryPhiladelphia$131K
- James MarkmannPhiladelphia$97K
- Daniel HewittPhiladelphia$89K
- Daniel HashimotoPhiladelphia$73K
- Scott KozinPhiladelphia$59K
- Prashanth PalvannanPhiladelphia$54K
- Henry HirschPhiladelphia$53K
- Erica PettkePhiladelphia$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.